New Hepatitis B Guidelines: A Shift in Care

The Daily Brief — Saturday, December 6, 2025

A concise, nonpartisan roundup from roughly the past 24 hours. Focused on signal, incentives, and what could matter to outcomes.

US News

  • CDC advisory panel narrows newborn hepatitis B guidance: On Dec 5, the CDC’s ACIP voted to end the universal “birth‑dose” recommendation, limiting it to babies of mothers who are hepatitis B–positive or of unknown status, with others handled via clinician–parent decision‑making. Medical groups warn this could raise infant infection risk after three decades of progress. Final adoption awaits the CDC director. (reuters.com)
  • High court trend watch: With multiple cases this term touching executive power and campaign rules, the Supreme Court appears more willing to revisit—and potentially overturn—precedent, continuing a multi‑year shift with broad policy implications. (reuters.com)
  • Immigration policy marker: Homeland Security Secretary Kristi Noem signaled plans to expand the U.S. travel‑ban list to “over 30” countries (no list yet), underscoring a harder line on admissions. (theguardian.com)

Global News

  • Ukraine endures one of the war’s largest aerial barrages: Russia launched more than 650 drones and 50+ missiles overnight, striking energy and transport nodes across at least eight regions. Poland scrambled jets as a precaution. Ukraine reported rail disruptions near Kyiv and power constraints nationwide. (reuters.com)
  • Zaporizhzhia nuclear plant briefly lost external power: The IAEA said Europe’s largest nuclear plant went dark for ~30 minutes before lines were restored; other Ukrainian nuclear plants cut output due to grid instability. Radiation levels remained normal. (reuters.com)
  • Fast diplomacy amid escalation: Reports noted parallel U.S.-linked talks with Ukrainian officials even as strikes continued, highlighting the gap between battlefield tempo and political signaling. (apnews.com)

Science

  • Materials/energy safety spotlighted by Ukraine grid shocks: The IAEA’s update on Zaporizhzhia underscores how civilian nuclear safety hinges on reliable external power for cooling—even during shutdown—making grid resilience a scientific and engineering priority. (reuters.com)
  • Origin‑of‑life/evolution research (notable this week): A Nature study (Dec 3) proposes complex cellular features began evolving ~2.9 billion years ago—well before oxygen rose—reframing timelines for eukaryote assembly (“CALM” model). While a few days old, it’s a high‑signal result likely to echo through astrobiology and geobiology. (bristol.ac.uk)

Technology

  • Google antitrust remedies tighten distribution power: Following the 2024 monopoly verdict, a new ruling reported Friday requires Google to limit default‑placement contracts (e.g., with Apple/Samsung) to one‑year terms, creating recurring openings for rivals. Earlier, the court barred exclusivity and ordered limited data‑sharing with competitors while allowing Google to keep Chrome. Expect annual bidding to shift partner leverage and margins. (businessinsider.com)
  • AI product cadence accelerates: Multiple outlets report OpenAI is expediting a GPT‑5.2 release as soon as Dec 9 in response to Google’s latest Gemini advances; OpenAI hasn’t formally confirmed timing. If accurate, watch for training‑stack and memory bottlenecks as key constraints, not just model size. (theverge.com)

Business & Markets

  • Equities near records on Fed‑cut odds: Friday’s tape showed broad weekly gains as cooling PCE data and sentiment readings reinforced expectations for a 25 bp cut at next week’s FOMC. Breadth improved, with transports and small caps participating. (reuters.com)
  • Energy: Crude posted a second straight weekly gain on cut hopes and geopolitical risk (Russia/Venezuela), with Brent and WTI at two‑week highs into the weekend. (ewfpro.com)
  • Metals: Copper’s late‑November breakout to fresh records remains a key macro tell—tight mine supply and low inventories keep the market sensitive to tariff chatter and grid build‑out demand. (investing.com)

What a Munger‑style observer might underline

  1. Policy beats platitudes: ACIP’s hepatitis B pivot is a small vote with large externalities—where liability, logistics, and asymmetric information collide. Hospitals will face higher coordination costs; insurers and pediatric societies may become de‑facto standard‑setters. Incentives, not statements, will drive uptake. (reuters.com)
  2. Default positions are moats: For a decade, search dominance rode long‑duration defaults. Annual rebids and anti‑exclusivity remedies shift bargaining power to distributors (Apple, carriers) and invite new AI front‑ends to compete every year—an annuity turning into an auction. (businessinsider.com)
  3. Follow bottlenecks upstream: Markets are already pricing the constraint—HBM memory, refined copper, grid capacity. The AI story migrates from model hype to materials and energy throughput; that’s where pricing power accrues. (investing.com)
  4. Safety margins matter: A 30‑minute power loss at a shut‑down nuclear plant moves no stock ticker—but it’s a real‑world reminder that redundancy and boring engineering often decide tail risks. (reuters.com)

Time reference: Developments reflect reporting through Saturday, December 6, 2025 (U.S. Eastern).